Clinical trials: Cancer-Associated Pain
Intractable Pain, Palliative Care
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
This study will examine the safety of giving the experimental drug, resiniferatoxin (RTX), to treat severe pain in patients with advanced cancer. RTX is a chemical extracted from a cactus-like plant.
- Trial name
- NCT00804154
- Testing
- Intrathecal Resiniferatoxin
- Where
- United States
- Volunteers
- 36 people
- Sponsor
- National Institute of Dental and Craniofacial Research (NIDCR)
Cancer Pain
Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids
Cancer patients taking regular medication for their pain often still have episodes of severe pain that 'break through' despite their background pain treatment.
- Trial name
- NCT00459277
- Testing
- Fentanyl (Nasalfent, Fentanyl Citrate Nasal Spray)
- Where
- United States
- Volunteers
- 73 people
- Sponsor
- Archimedes Development Ltd
Abdominal Cancer
Radiofrequency and Chemical Neurolysis of Thoracic Splanchnic Nerve for Abdominal Cancer Pain
The study compares between the efficacy, safety and impact on the quality of life of radiofrequency thermocoagulation and chemical neurolysis of bilateral thoracic splanchnic nerves in the management of refractory pain which…
- Trial name
- RF (NCT03063112)
- Testing
- Radiofrequency generator device, Lidocaine, C arm fluoroscopic device
- Where
- Egypt
- Volunteers
- 79 people
- Sponsor
- South Egypt Cancer Institute
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
A Phase II Trial for MOR Antagonism With Axelopran to Enhance Immunotherapy in Head and Neck Cancer
This Phase 2, open-label, multicenter study will evaluate the safety and preliminary efficacy of axelopran in combination with pembrolizumab in patients with PD-L1 positive recurrent or metastatic head and neck squamous cell…
- Trial name
- MORALE-HN01 (NCT07662720)
- Testing
- axelopran, Pembolizumab
- Volunteers
- 18 people
- Sponsor
- Glycyx Therapeutics
Myofascial Pain Syndromes, Cancer
Efficacy of Myofascial Pain Syndrome Treatment in Patients With Cancer in Palliative Care
Palliative Care is active holistic care offered to people who are in intense suffering related to their health, resulting from a serious life-threatening illness, with a focus on improving the quality of life.
- Trial name
- NCT04703803
- Testing
- 1% lidocaine injection in trigger points
- Where
- Brazil
- Volunteers
- 30 people
- Sponsor
- University of Sao Paulo
Cancer Pain
Transdiscal vs Paravertebral Neurolytic Splanchnic Nerve Block for Upper Abdominal Cancer Pain
This study aims to compare the efficacy of fluoroscopy-guided paravertebral (PV) and transdiscal (TD) approaches for splanchnic nerve neurolysis in patients with upper abdominal cancer-related pain (e.g., gastric, pancreatic, and…
- Trial name
- NCT07445386
- Testing
- transdiscal splanchnic neurolysis, paravertebral splanchnic neurolysis
- Where
- Turkey (Türkiye)
- Volunteers
- 56 people
- Sponsor
- Ankara Etlik City Hospital
Cancer Pain, Quality of Life
Safety and Efficacy of Inhaled Cannabis For the Uncontrolled Pain Relief in Patients With Advanced Cancer
This phase 2 multicenter clinical trial assess the safety and efficacy of inhaled PPP001 to relieve the pain in 78 advanced cancer patients with uncontrolled symptoms.
- Conditions
- Cancer Pain, Quality of Life, Pain, Acute, Cannabis Use
- Trial name
- PLENITUDE (NCT04042545)
- Testing
- PPP001
- Where
- United States
- Volunteers
- 78 people
- Sponsor
- Tetra Bio-Pharma
Cancer, Pain
Intranasal (NAS) Ketamine for Cancer Pain
The main purpose of this study is to determine the safety, feasibility, and utility of intranasal (NAS) ketamine in persistent uncontrolled cancer related pain.
- Trial name
- NCT03146806
- Testing
- Intranasal ketamine
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Emory University
Pain, Intractable
Effectiveness of Ketamine in Malignant Neuropathic Pain Relief
To see whether the addition of low-dose ketamine to a subcutaneous morphine infusion improves analgesia in patients with neuropathic cancer pain.
- Trial name
- KETA-1 (NCT01951911)
- Testing
- Ketamine
- Where
- Norway
- Sponsor
- Haukeland University Hospital
Advanced Cancer
Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated
The purpose of this study is to describe how often advanced cancer patients experience breakthrough pain (BTcP), and to describe how this pain is treated, and how effective these treatments are.
- Trial name
- Break-1 (NCT02069067)
- Where
- 3 sites in Italy
- Volunteers
- 500 people
- Sponsor
- National Cancer Institute, Naples
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Aromatherapy Oil Associated for Managing Anxiety and Pain During Bone Marrow Biopsy Procedures
This clinical trial evaluates whether using aromatherapy can reduce pain and anxiety for cancer patients during routine biopsy procedures.
- Trial name
- NCT06581211
- Testing
- Aromatherapy and Essential Oils, Electronic Health Record Review, Jojoba Oil
- Where
- 2 sites in United States
- Volunteers
- 45 people
- Sponsor
- City of Hope Medical Center
Cancer Pain
Effects of Mobile Medicine on Cancer Patients
With the existing medical system and insufficient medical resources in China, we developed a mini program. a pain management mini app can be useful and appreciated by patients and health care professionals, making it a good…
- Trial name
- NCT05049811
- Testing
- mini program, conventional pharmaceutical care
- Volunteers
- 200 people
- Sponsor
- Fujian Cancer Hospital
Analgesics, Opioid, Pain
A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain
The purpose of this repeated dose study is to develop recommended dosing information for initiation of therapy with OROS Hydromorphone HCI (slow release) in patients with chronic cancer pain converting from other strong oral or…
- Trial name
- NCT00411034
- Testing
- OROS Hydromorphone HCI
- Volunteers
- 463 people
- Sponsor
- Alza Corporation, DE, USA
Pain, Cancer
A Phase III Clinical Study of KW-2246
This study is designed to assess the safety and efficacy of long-term KW-2246 treatment as rescue medication for breakthrough pain.
- Trial name
- NCT00683995
- Testing
- KW-2246 (fentanyl citrate)
- Where
- 20 sites in Japan
- Volunteers
- 43 people
- Sponsor
- Kyowa Kirin Co., Ltd.
Opioid Withdrawal (Disorder)
Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal
Stopping prescription opioid pain medications can be difficult due to withdrawal symptoms. This study will test if LUCEMYRA helps reduce withdrawal symptoms and helps more people reduce their opioid dose compared to placebo.
- Trial name
- TAPER (NCT04070157)
- Testing
- Lofexidine
- Where
- 12 sites in United States
- Volunteers
- 4 people
- Sponsor
- USWM, LLC (dba US WorldMeds)
Cancer Rectum, Cancer Vulva
Interventions for the Management of Perineal Cancer Pain
Pain associated with neoplasms may be of somatic, visceral, or neuropathic origin.Visceral pain or pain that is mediated by the sympathetic fibers in the perineal area associated with malignancy in the pelvis may be effectively…
- Conditions
- Cancer Rectum, Cancer Vulva, Cancer Vagina
- Trial name
- NCT06392399
- Testing
- cooled radiofrequency ,, conventional radiofrequency, neurolysis of ganglion
- Volunteers
- 60 people
- Sponsor
- Assiut University
Cancer, Pain
An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain
The purpose of this study is to evaluate safety/tolerability and clinical utility of low-dose transdermal therapeutic system (TTS [medicated adhesive pad that is placed on the skin to deliver a timed-release dose of medication…
- Trial name
- NCT00771199
- Testing
- Transdermal Therapeutic System (TTS)-Fentanyl
- Where
- United Kingdom
- Volunteers
- 14 people
- Sponsor
- Janssen-Cilag Ltd.
Neoplasm Metastasis
Pilot Study to Test the Feasibility and the Efficacy of the German Language Adapted PRO-SELF© Plus Pain Control Program
The purpose of this pilot study is to refine and test an advanced and adapted German version of the PRO-SELF© Plus Pain Control Program (PCP), an educational intervention directed at cancer pain patients and their families to…
- Trial name
- PEINCA (NCT00920504)
- Testing
- German PRO-SELF(c) Plus Pain Control Program (PCP), Standard Care
- Where
- Germany
- Volunteers
- 39 people
- Sponsor
- University Hospital, Basel, Switzerland
Pain, Cancer Pain
PENS or TENS for Pain in Liver Cancer
This study evaluates the effect of percutaneous electrical nerve stimulation (PENS) and transcutaneous nerve stimulation (TENS) for pain relieving in patients with liver cancer.
- Conditions
- Pain, Cancer Pain, Liver Neoplasms
- Trial name
- NCT03338543
- Testing
- PENS, TENS
- Where
- China
- Volunteers
- 36 people
- Sponsor
- Fuda Cancer Hospital, Guangzhou
Cancer Pains
Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain
Many patients with cancer experience moderate to severe pain that requires treatment with strong opioids, of which oxycodone and morphine are examples, they are widely applied in clinical treatment because of sustained-released…
- Trial name
- NCT03639415
- Testing
- Increasing the Controlled-Release Oxycodone dose frequency
- Volunteers
- healthy volunteers welcome
- Sponsor
- Fujian Cancer Hospital